The cannabis plant and its constituent compounds, primarily cannabinoids like Tetrahydrocannabinol (THC) and Cannabidiol (CBD), interact with the body's endocannabinoid system (ECS). This interaction regulates a wide array of physiological and psychological processes, forming the biological foundation for its diverse medical applications.

Primary Therapeutic Domains

Cannabis is utilized for a broad spectrum of medical conditions, often as an alternative or complementary treatment.

1. Neurological Disorders

CBD has demonstrated significant anticonvulsant properties and is FDA-approved for treating specific severe forms of epilepsy.

• Epilepsy: Approved for Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous Sclerosis Complex (TSC).
• Multiple Sclerosis (MS): Researched for its potential to reduce muscle spasticity and associated pain.
• Parkinson's Disease: Investigated for alleviating sleep disorders and psychosis related to the disease.

2. Pain Management

Cannabinoids are increasingly explored for managing various types of chronic and acute pain through their anti-inflammatory and analgesic properties.

• Chronic Pain: Studies suggest efficacy in managing neuropathic and inflammatory pain.
• Arthritis: Targeted through both oral supplements and topical applications to reduce localized inflammation.
• Migraines: Some individuals report relief from migraine symptoms, though controlled studies are ongoing.

3. Mental Health and Wellness

CBD interacts with the ECS to impact mood regulation and systemic well-being.

• Anxiety Disorders: Research indicates potential for reducing symptoms of Generalized Anxiety Disorder (GAD), PTSD, and social anxiety.
• Insomnia: May improve sleep quality by addressing underlying causes such as anxiety or chronic pain.
• Systemic Relief: Integrated into wellness routines to support overall homeostasis.

4. Appetite Stimulation

THC is medically recognized for its ability to increase appetite, often referred to as inducing "the munchies".

• Mechanisms: THC binds to CB1 receptors, increasing the sense of smell and taste while releasing the "hunger hormone" ghrelin.
• Target Conditions: Particularly beneficial for patients with cancer (chemotherapy-induced loss of appetite), HIV/AIDS (wasting syndrome), and chronic pain-related cachexia.

Comparison of Active Compounds

Compound	Psychoactivity	Primary Medical Effects	Receptor Interaction
THC	Psychoactive	Appetite stimulation, euphoria, pain relief	Binds directly to CB1 receptors
CBD	Non-psychoactive	Anti-seizure, anti-anxiety, anti-inflammatory	Indirect/Low affinity for CB1/CB2

Delivery and Onset for Medical Use

The method of consumption dictates the speed and duration of the therapeutic effect.

• Inhalation (Vaping/Smoking): Rapid onset (seconds to minutes); duration 1–4 hours. Best for acute symptoms like sudden pain or nausea.
• Oral Ingestion (Edibles): Slower onset (30–120 minutes); longer-lasting effects (4–8 hours). Ideal for chronic conditions requiring sustained relief.
• Sublingual (Tinctures/Sprays): Onset in 15–45 minutes; duration 2–6 hours. Offers more precise dosing than edibles.
• Topical Application: Localized relief for muscles and joints with no psychoactive risk.